|
1
|
Daskalogianni C, Pyndiah S, Apcher S,
Mazars A, Manoury B, Ammari N, Nylander K, Voisset C, Blondel M and
Fåhraeus R: Epstein-Barr virus-encoded EBNA1 and ZEBRA: Targets for
therapeutic strategies against EBV-carrying cancers. J Pathol.
235:334–341. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nishikawa J, Yoshiyama H, Iizasa H,
Kanehiro Y, Nakamura M, Nishimura M, Saito M, Okamoto T, Sakai K,
Suehiro Y, et al: Epstein-Barr Virus in Gastric Carcinoma. Cancers.
6:2259–2274. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen JN, Ding YG, Feng ZY, Li HG, He D, Du
H, Wu B and Shao CK: Association of distinctive Epstein-Barr virus
variants with gastric carcinoma in Guangzhou, southern China. J Med
Virol. 82:658–667. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sivachandran N, Dawson CW, Young LS, Liu
FF, Middeldorp J and Frappier L: Contributions of the Epstein-Barr
virus EBNA1 protein to gastric carcinoma. J Virol. 86:60–68. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kennedy G, Komano J and Sugden B:
Epstein-Barr virus provides a survival factor to Burkitt's
lymphomas. Proc Natl Acad Sci USA. 100:14269–14274. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Young SL, Dawson WC and Eliopoulos GA: The
expression and function of Epstein-Barr virus encoded latent genes.
Mol Pathol. 53:238–247. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Humme S, Reisbach G, Feederle R, Delecluse
HJ, Bousset K, Hammerschmidt W and Schepers A: The EBV nuclear
antigen 1 (EBNA1) enhances B cell immortalization several
thousandfold. Proc Natl Acad Sci USA. 100:10989–10994. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Iizasa H, Nanbo A, Nishikawa J, Jinushi M
and Yoshiyama H: Epstein-Barr virus (EBV)-associated gastric
carcinoma. Viruses. 4:3420–3439. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hannon GJ: RNA interference. Nature.
418:244–251. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang Z, Wang J, Shen B, Peng C and Zheng
M: The ABCC4 gene is a promising target for pancreatic cancer
therapy. Gene. 491:194–199. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li L, Ma BB, Chan AT, Chan FK, Murray P
and Tao Q: Epstein-Barr virus-induced epigenetic pathogenesis of
viral-associated lymphoepithelioma-like carcinomas and natural
killer/T-cell lymphomas. Pathogens. 7:E632018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tokunaga M and Land CE: Epstein-Barr virus
involvement in gastric cancer: Biomarker for lymph node metastasis.
Cancer Epidemiol Biomarkers Prev. 7:449–450. 1998.PubMed/NCBI
|
|
14
|
Ian MX, Lan SZ, Cheng ZF, Dan H and Qiong
LH: Suppression of EBNA1 expression inhibits growth of EBV-positive
NK/T cell lymphoma cells. Cancer Biol Ther. 7:1602–1606. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sivachandran N, Sarkari F and Frappier L:
Epstein-Barr nuclear antigen 1 contributes to nasopharyngeal
carcinoma through disruption of PML nuclear bodies. PLoS Pathog.
4:e10001702008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Frappier L: Contributions of Epstein-Barr
nuclear antigen 1 (EBNA1) to cell immortalization and survival.
Viruses. 4:1537–1547. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chuang TC, Lee YJ, Liu JY, Lin YS, Li JW,
Wang V, Law SL and Kao MC: EBNA1 may prolong G(2)/M phase and
sensitize HER2/neu-overexpressing ovarian cancer cells to both
topoisomerase II-targeting and paclitaxel drugs. Biochem Biophys
Res Commun. 307:653–659. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hong M, Murai Y, Kutsuna T, Takahashi H,
Nomoto K, Cheng CM, Ishizawa S, Zhao QL, Ogawa R, Harmon BV, et al:
Suppression of Epstein-Barr nuclear antigen 1 (EBNA1) by RNA
interference inhibits proliferation of EBV-positive Burkitt's
lymphoma cells. J Cancer Res Clin Oncol. 132:1–8. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yin Q and Flemington EK: siRNAs against
the Epstein-Barr virus latency replication factor, EBNA1, inhibit
its function and growth of EBV-dependent tumor cells. Virology.
346:385–393. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Saridakis V, Sheng Y, Sarkari F, Holowaty
MN, Shire K, Nguyen T, Zhang RG, Liao J, Lee W, Edwards AM, et al:
Structure of the p53 binding domain of HAUSP/USP7 bound to
Epstein-Barr nuclear antigen 1 implications for EBV-mediated
immortalization. Mol Cell. 18:25–36. 2005. View Article : Google Scholar : PubMed/NCBI
|
